Prostate-specific antigen use among men without prostate cancer in France (2008-2010);Consommation du dosage de l'antigène spécifique de la prostate (PSA) en France chez les hommes sans cancer de la prostate déclaré (2008-2010)

Bulletin du Cancer

Volumn 99, Issue 5, 2012, Pages 521-527

  Tuppin, Philippe ^a   Samson, Solène ^a   Perrin, Paul ^b   Ruffion, Alain ^b   Millat, Bertrand ^a   Weill, Alain ^a   Ricordeau, Philippe ^a   Allemand, Hubert ^a  

^a Caisse Nationale d'Assurance Maladie des Travailleurs Salaries   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Age; France; Prostate cancer; Prostate specific antigen (PSA); Screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SCREENING; FRANCE; GENERAL PRACTITIONER; HUMAN; MALE; PROSTATE CANCER; SOCIAL SECURITY; UROLOGIST;

EID: 84861422230     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2012.1580     Document Type: Article

References (21)

1. Daubisse-Marliac I, Grosclaude P. Projection de l'incidence et de la mortalité par cancer en France en 2011 : prostate. Saint-Maurice : Institut de veille sanitaire, 2011, www.invs.sante.fr.
2. Institut National du Cancer. Incidence et mortalité des cancers (épidémiologie), 2012. lesdonnees.e-cancer.fr.
3. Collin SM, Martin RM, Metcalfe C, et al. Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study. Lancet Oncol 2008; 9 : 445-52.
4. Inserm. Centre d'épidémiologie sur les causes médicales de décès. www.cepidc.vesinet.inserm.fr.
5. Hill C, Doyon F, Mousannif A. Évolution de la mortalité par cancer en France de 1950 à 2006. Saint-Maurice : Institut de veille sanitaire, 2009, www.invs.sante.fr.
6. Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostatecancer mortality in a randomized European study. N Engl J Med 2009; 360 : 1320-8.
7. Andriole GL, Crawford ED, Grubb RLI, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009; 360 : 1310-9.
8. Andriole GL, Crawford ED, Grubb 3rd RL, et al. Prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: mortality results after 13 years of follow-up. J Natl Cancer Inst 2012; 104 : 125-32.
9. Haute Autorité de Santé (HAS). Dépistage du cancer de la prostate - analyse critique des articles issus des études ERSPC et PLCO publiés en mars 2009. Rapport d'orientation. Paris : HAS, 2010, www.has-sante.fr.
10. Haab F, Beley S, Cornu JN, Culine S, Cussenot O, Hennequin C. Séquelles fonctionnelles de la prise en charge du cancer de prostate localisé. Bull Cancer 2010; 97 : 1537-49.
11. Chou R, Croswell JM, Dana T, et al. Screening for prostate cancer: a review of the evidence for the U.S. preventive services task force. Ann Intern Med 2011; 155 : 762-71.
12. Williams N, Hughes LJ, Turner EL, et al. Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities. BJU Int 2011; 108 : 1402-8.
13. Jonsson H, Holmström B, Duffy SW, Stattin P. Uptake of prostate-specific antigen testing for early prostate cancer detection in Sweden. Int J Cancer 2011; 129 : 1881-8.
14. Drazer MW, Huo D, Schonberg MA, Razmaria A, Eggener SE. Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States. J Clin Oncol 2011; 29 : 1736-43.
15. Djulbegovic M, Beyth RJ, Neuberger MM, et al. Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials. BMJ 2010; 341 : c4543.
16. Sandblom G, Varenhorst E, Rosell J, Lofman O, Carlsson P. Randomised prostate cancer screening trial: 20 year follow-up. BMJ 2011 ; 342 : d1539.
17. Soulié M, Rebillard X, Villers A. Prostate cancer screening. Prog Urol 2003; 13 : 209-14.
18. Brawley OW, Gansler T. Introducing the 2010 American Cancer Society prostate cancer screening guideline. CA Cancer J Clin 2010; 60 : 68-9.
19. Brooks DD,Wolf A, Smith RA, Dash C, Guessous I. Prostate cancer screening 2010: updated recommendations from the American Cancer Society. J Natl Med Assoc 2010; 102 : 423-9.
20. Sima CS, Panageas KS, Schrag D. Cancer screening among patients with advanced cancer. JAMA 2010; 304 : 1584-91.
21. Walter LC, Bertenthal D, Lindquist K, Konety BR. PSA screening among elderly men with limited life expectancies. JAMA 2006; 296 : 2336-42. (Pubitemid 44749361)